Regenerative medicine

1 marketed 1 in Phase 3 2 in Phase 2

This page covers all Regenerative medicine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

Reactivation Mismatch · Massachusetts General Hospital · Regenerative medicine, Orthopedics
Reactivation Mismatch is a treatment that helps restore the body's natural ability to repair and regenerate damaged tissues.

Phase 3 pipeline (1)

denovoSkin(TM) · CUTISS AG · Dermatology
denovoSkin(TM) is a regenerative medicine treatment that uses a patient's own skin cells to repair damaged skin.

Phase 2 pipeline (2)

Autologous Apheresis PRP Injection · zhang li · Orthopedics, Wound care
Autologous Apheresis PRP Injection is a regenerative medicine treatment that uses a patient's own platelet-rich plasma to stimulate healing and tissue repair.
Autologous Engineered Skin Substitute · Amarantus BioScience Holdings, Inc. · Dermatology
Autologous Engineered Skin Substitute is a regenerative medicine that uses a patient's own cells to promote skin healing.